Henri Portier
Impact in
- Virology top 2%
- HIV Research and Treatment
- Infectious Diseases top 1%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
- Antifungal resistance and susceptibility
Papers in
-
- HIV/AIDS drug development and treatment 16
- Antimicrobial Resistance in Staphylococcus 10
- Epidemiology 43
- Pneumonia and Respiratory Infections 22
- Co-authors
- P. Chavanet (76 shared papers)Lionel Piroth (37 shared papers)Michel Duong (38 shared papers)Michèle Grappin (30 shared papers)Marielle Buisson (21 shared papers)Jean‐Michel Petit (7 shared papers)P. Dellamonica (3 shared papers)Anne Waldner (6 shared papers)
- Journals
- Journal of Antimicrobial Chemotherapy (9 papers)The Lancet (7 papers)HIV Clinical Trials (6 papers)AIDS (6 papers)Antimicrobial Agents and Chemotherapy (5 papers)
- Partner nations
- FranceUnited StatesSwitzerland
In The Last Decade
Henri Portier
112 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 110
- Virology 346
- Infectious Diseases 1.3k
- Emergency Medicine 497
- Hepatology 327
- Molecular Medicine 211
Countries citing papers authored by Henri Portier
This map shows the geographic impact of Henri Portier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henri Portier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henri Portier more than expected).
Fields of papers citing papers by Henri Portier
This network shows the impact of papers produced by Henri Portier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henri Portier. The network helps show where Henri Portier may publish in the future.
Co-authors
The 25 scholars most cited alongside Henri Portier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 118 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 330 | |
| 2 | 1998 | 170 | |
| 3 | 2001 | 111 | |
| 4 | 2003 | 102 | |
| 5 | 2002 | 93 | |
| 6 | 2004 | 92 | |
| 7 | 2001 | 88 | |
| 8 | 1992 | 87 | |
| 9 | 2001 | 77 | |
| 10 | 1999 | 70 | |
| 11 | 1994 | 69 | |
| 12 | 2004 | 67 | |
| 13 | 2015 | 63 | |
| 14 | 1992 | 60 | |
| 15 | 1990 | 59 | |
| 16 | 1994 | 53 | |
| 17 | 2000 | 51 | |
| 18 | 1997 | 49 | |
| 19 | 2006 | 49 | |
| 20 | 1980 | 47 |
About Henri Portier
Henri Portier is a scholar working on Infectious Diseases, Epidemiology, Microbiology, Emergency Medicine and Pharmacology, having authored 118 papers that have together received 3.1k indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (22 papers), Antibiotics Pharmacokinetics and Efficacy (18 papers), HIV/AIDS drug development and treatment (16 papers), HIV-related health complications and treatments (14 papers), Antibiotic Resistance in Bacteria (11 papers), Bacterial Infections and Vaccines (10 papers), Streptococcal Infections and Treatments (10 papers) and Antimicrobial Resistance in Staphylococcus (10 papers). The work is most often cited by research in Virology (346 citations), Infectious Diseases (1.3k citations), Emergency Medicine (497 citations), Hepatology (327 citations) and Molecular Medicine (211 citations). Henri Portier has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include P. Chavanet, Lionel Piroth, Michel Duong, Michèle Grappin, Marielle Buisson, Jean‐Michel Petit, P. Dellamonica, Anne Waldner, Pierre‐Emmanuel Charles and Guy Humbert. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, The Lancet, HIV Clinical Trials, AIDS and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.